Advertisement
Advertisement

DWTX

DWTX logo

Dogwood Therapeutics, Inc. Common Stock

2.81
USD
Sponsored
-0.09
-3.10%
Jan 30, 16:00 UTC -5
Closed
exchange

After-Market

2.83

+0.02
+0.71%

DWTX Earnings Reports

Positive Surprise Ratio

DWTX beat 11 of 18 last estimates.

61%

Next Report

Date of Next Report
Mar 30, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$1.18
Implied change from Q3 25 (Revenue/ EPS)
--
/
-85.59%
Implied change from Q4 24 (Revenue/ EPS)
--
/
-79.90%

Dogwood Therapeutics, Inc. Common Stock earnings per share and revenue

On Nov 06, 2025, DWTX reported earnings of -8.19 USD per share (EPS) for Q3 25, missing the estimate of -1.24 USD, resulting in a -556.26% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -6.47% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 analysts forecast an EPS of -1.18 USD, with revenue projected to reach -- USD, implying an decrease of -85.59% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
FAQ
For Q3 2025, Dogwood Therapeutics, Inc. Common Stock reported EPS of -$8.19, missing estimates by -556.26%, and revenue of $0.00, 0% as expectations.
The stock price moved down -6.47%, changed from $5.56 before the earnings release to $5.20 the day after.
The next earning report is scheduled for Mar 30, 2026.
Based on 5 analysts, Dogwood Therapeutics, Inc. Common Stock is expected to report EPS of -$1.18 and revenue of -- for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement